Ronen Schneider
MD, Medical Director, Renal Genetics Natera
Seminars
Tuesday 17th March 2026
From Genotype to Outcomes: RenasightIQ Real-World Evidence in Glomerular Diseases
9:00 am
- This presentation highlights real-world evidence from RenasightIQ to demonstrate how integrated clinical and genetic data are transforming risk stratification and treatment optimization in glomerular disease
- With focused insights from genetic ancestry, we will examine how genetic drivers influence disease trajectory and therapeutic response
- The session will also review real-world treatment effects of steroids/immunosuppression, ACE inhibitors/ARBs, and SGLT2 inhibitors
- Together, these findings underscore how precision medicine approaches can improve prognostic clarity, guide treatment decisions, and drive better patient outcomes
